GuiDeCode
Calcs › ⚕ Critical Care / ICU

HACOR Score for NIV Failure

Predicts failure of noninvasive ventilation (NIV) in hypoxemic patients at 1–2 hours after initiation

Calculator

Loading calculator…

Why use it

NIV is increasingly used for acute hypoxemic respiratory failure but fails in 30–50% of patients. Delayed recognition of NIV failure — continuing NIV for more than 1–2 hours in patients who are not responding — is associated with a 2-fold or greater increase in ICU mortality compared to early intubation. The HACOR score provides a simple, validated tool to identify patients who are unlikely to succeed with NIV, allowing timely transition to invasive mechanical ventilation before further respiratory and hemodynamic deterioration.

About

The HACOR score was developed by Liu and colleagues and published in Critical Care in 2017 to predict failure of noninvasive ventilation (NIV) in patients with acute hypoxemic respiratory failure. The acronym encodes five physiological variables assessed 1–2 hours after NIV initiation: Heart rate, Acidosis (arterial pH), Consciousness (Glasgow Coma Scale), Oxygenation (PaO2/FiO2 ratio), and Respiratory rate. Each variable is assigned weighted points based on its degree of abnormality, with total scores ranging from 0 to 16. A HACOR score ≥5 at 1–2 hours of NIV initiation has been validated as the optimal threshold for predicting NIV failure (defined as intubation or death during NIV), with a sensitivity of 72% and specificity of 73% and an AUC of 0.80 in the validation cohort. The score was derived from 449 patients with acute hypoxemic respiratory failure in the ICU and validated in a separate cohort of 302 patients. Early identification of NIV failure is critical because delayed intubation in NIV-failing patients is independently associated with significantly higher ICU mortality compared to timely intubation.

When to use

  • Assessment at 1–2 hours after NIV initiation in patients with acute hypoxemic respiratory failure
  • Monitoring NIV response in ARDS, pneumonia, cardiogenic pulmonary edema, or immunocompromised patients with respiratory failure
  • Identifying patients requiring early escalation to invasive mechanical ventilation
  • Serial assessment (every 1–2 hours) during NIV in deteriorating patients
  • NOT intended for patients with acute hypercapnic failure (COPD exacerbation) — primarily validated in hypoxemic failure

Formula

HACOR Score (assessed at 1–2h after NIV initiation): H — Heart Rate (bpm): ≤ 120: 0 > 120: +2 A — Acidosis (arterial pH): ≥ 7.35: 0 7.25–7.34: +2 < 7.25: +3 C — Consciousness (GCS): 14–15: 0 11–13: +2 ≤ 10: +4 O — Oxygenation (PaO2/FiO2, mmHg): > 300: 0 201–300: +1 151–200: +2 101–150: +3 ≤ 100: +4 R — Respiratory Rate (breaths/min): ≤ 25: 0 26–35: +2 > 35: +3 Total Range: 0–16 HACOR ≥ 5 at 1–2h = NIV failure predicted

Pearls & pitfalls

  • The HACOR score must be assessed at 1–2 hours after NIV initiation — this is the validated time point. Scores at initiation or much later are less predictive.
  • A HACOR score ≥5 at 1–2h carries sensitivity of ~72% and specificity of ~73% for NIV failure — it is a decision-support tool, not an absolute rule.
  • Consciousness (GCS) carries the highest maximum points (4) in the score — severely altered consciousness (GCS ≤10) should prompt immediate consideration of intubation regardless of other parameters.
  • HACOR ≥5 is associated with a 3-fold increase in ICU mortality if NIV is continued without improvement beyond this time point.
  • The score was primarily validated in immunocompromised patients and those with ARDS/pneumonia — performance in other causes of hypoxemic failure may differ.
  • All variables are measured WHILE THE PATIENT IS ON NIV — not pre-NIV baseline values.
  • Patients with HACOR ≥8 have NIV failure rates >90% — intubation is almost certainly indicated in these patients.
  • Low-dose awake prone positioning may be attempted as an adjunct to NIV in selected patients, but it does not replace the need to reassess HACOR and plan for intubation if failing.

Next steps

HACOR < 5 (NIV likely to succeed): Continue NIV with close monitoring. Reassess every 1–2 hours. Treat underlying cause. Optimize NIV settings (PEEP, FiO2, interface fit). HACOR ≥ 5 (NIV failure likely): Prepare for intubation. Notify attending/intensivist urgently. Mobilize airway resources. If no improvement within 30–60 minutes: proceed to intubation without further delay. HACOR ≥ 8: Urgent intubation — delay is strongly discouraged. Any HACOR score with: worsening consciousness (GCS dropping), hemodynamic instability, or respiratory arrest → immediate intubation regardless of score.

Evidence

Liu J et al. Early prediction of noninvasive ventilation failure in patients with hypoxemic respiratory failure. Crit Care. 2017;21(1):300. PMID:29258554. Derivation cohort: 449 patients (Sichuan University, China). Validation cohort: 302 patients. AUC 0.80. Optimal threshold HACOR ≥5: sensitivity 72%, specificity 73%. ICU mortality significantly higher with delayed intubation in HACOR ≥5 patients (p<0.001).

References

  1. Liu J et al. Early prediction of noninvasive ventilation failure in patients with hypoxemic respiratory failure. Crit Care. 2017;21(1):300. — link
  2. Frat JP et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185-2196. — link
  3. Antonelli M et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med. 1998;339(7):429-435. — link